TY - JOUR AU - Verma, V. AU - Li, J. AU - Lin, C. PY - 2016 DA - 2016// TI - Neoadjuvant therapy for pancreatic cancer: systematic review of postoperative morbidity, mortality, and complications JO - Am J Clin Oncol VL - 39 UR - https://doi.org/10.1097/COC.0000000000000278 DO - 10.1097/COC.0000000000000278 ID - Verma2016 ER - TY - JOUR AU - Perysinakis, I. AU - Avlonitis, S. AU - Georgiadou, D. AU - Tsipras, H. AU - Margaris, I. PY - 2015 DA - 2015// TI - Five-year actual survival after pancreatoduodenectomy for pancreatic head cancer JO - ANZ J Surg VL - 85 UR - https://doi.org/10.1111/ans.12422 DO - 10.1111/ans.12422 ID - Perysinakis2015 ER - TY - JOUR AU - Torres, M. P. AU - Rachagani, S. AU - Purohit, V. AU - Pandey, P. AU - Joshi, S. AU - Moore, E. D. PY - 2012 DA - 2012// TI - Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism JO - Cancer Lett VL - 323 UR - https://doi.org/10.1016/j.canlet.2012.03.031 DO - 10.1016/j.canlet.2012.03.031 ID - Torres2012 ER - TY - JOUR AU - Dutta, D. AU - Chakraborty, B. AU - Sarkar, A. AU - Chowdhury, C. AU - Das, P. PY - 2016 DA - 2016// TI - A potent betulinic acid analogue ascertains an antagonistic mechanism between autophagy and proteasomal degradation pathway in HT-29 cells JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2055-1 DO - 10.1186/s12885-016-2055-1 ID - Dutta2016 ER - TY - JOUR AU - Steele, J. C. AU - Warhurst, D. C. AU - Kirby, G. C. AU - Simmonds, M. S. PY - 1999 DA - 1999// TI - In vitro and in vivo evaluation of betulinic acid as an antimalarial JO - Phytother Res VL - 13 UR - https://doi.org/3.0.CO;2-1 DO - 3.0.CO;2-1 ID - Steele1999 ER - TY - JOUR AU - Jingbo, W. AU - Aimin, C. AU - Qi, W. AU - Xin, L. AU - Huaining, L. PY - 2015 DA - 2015// TI - Betulinic acid inhibits IL-1β-induced inflammation by activating PPAR-γ in human osteoarthritis chondrocytes JO - Int Immunopharmacol VL - 29 UR - https://doi.org/10.1016/j.intimp.2015.09.009 DO - 10.1016/j.intimp.2015.09.009 ID - Jingbo2015 ER - TY - JOUR AU - Aiken, C. AU - Chen, C. H. PY - 2005 DA - 2005// TI - Betulinic acid derivatives as HIV-1 antivirals JO - Trends Mol Med VL - 11 UR - https://doi.org/10.1016/j.molmed.2004.11.001 DO - 10.1016/j.molmed.2004.11.001 ID - Aiken2005 ER - TY - JOUR AU - Wang, Z. AU - Mudalal, M. AU - Sun, Y. PY - 2020 DA - 2020// TI - The effects of leukocyte-platelet rich fibrin (L-PRF) on suppression of the expressions of the pro-inflammatory cytokines, and proliferation of schwann cell, and neurotrophic factors.[J] JO - Sci Rep VL - 10 UR - https://doi.org/10.1038/s41598-020-59319-2 DO - 10.1038/s41598-020-59319-2 ID - Wang2020 ER - TY - JOUR AU - Wang, W. AU - Wang, Y. AU - Liu, M. PY - 2019 DA - 2019// TI - Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivo.[J] JO - J Cell Mol Med VL - 23 UR - https://doi.org/10.1111/jcmm.13964 DO - 10.1111/jcmm.13964 ID - Wang2019 ER - TY - JOUR AU - Yu, S. AU - Zhang, Y. AU - Li, Q. PY - 2019 DA - 2019// TI - CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.[J] JO - Cell Death Dis VL - 10 UR - https://doi.org/10.1038/s41419-019-2168-y DO - 10.1038/s41419-019-2168-y ID - Yu2019 ER - TY - JOUR AU - Zhang, G. AU - Feng, W. AU - Wu, J. PY - 2020 DA - 2020// TI - Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).[J] JO - Biomed Pharmacother VL - 125 UR - https://doi.org/10.1016/j.biopha.2019.109768 DO - 10.1016/j.biopha.2019.109768 ID - Zhang2020 ER - TY - JOUR AU - Wolfgang, C. L. AU - Herman, J. M. AU - Laheru, D. AU - Klein, A. P. AU - Erdek, M. A. AU - Fishman, E. K. AU - Hruban, R. H. PY - 2013 DA - 2013// TI - Recent progress in pancreatic cancer JO - CA Cancer J Clin VL - 63 UR - https://doi.org/10.3322/caac.21190 DO - 10.3322/caac.21190 ID - Wolfgang2013 ER - TY - JOUR AU - Heinemann, V. PY - 2001 DA - 2001// TI - Gemcitabine: progress in the treatment of pancreatic cancer JO - Oncology. VL - 60 UR - https://doi.org/10.1159/000055290 DO - 10.1159/000055290 ID - Heinemann2001 ER - TY - JOUR AU - George, S. AU - Bhalerao, S. V. AU - Lidstone, E. A. AU - Ahmad, I. S. AU - Abbasi, A. AU - Cunningham, B. T. AU - Watkin, K. L. PY - 2010 DA - 2010// TI - Cytotoxicity screening of Bangladeshi medicinal plant extracts on pancreatic cancer cells JO - BMC Complement Altern Med VL - 10 UR - https://doi.org/10.1186/1472-6882-10-52 DO - 10.1186/1472-6882-10-52 ID - George2010 ER - TY - JOUR AU - Wang, J. AU - Wang, Z. AU - Wang, X. PY - 2019 DA - 2019// TI - Combination of Alprazolam and Bailemian capsule improves the sleep quality in patients with post-stroke insomnia: a retrospective study JO - Front Psychiatry VL - 10 UR - https://doi.org/10.3389/fpsyt.2019.00411 DO - 10.3389/fpsyt.2019.00411 ID - Wang2019 ER - TY - JOUR AU - Yogeeswari, P. AU - Sriram, D. PY - 2005 DA - 2005// TI - Betulinic acid and its derivatives: a review on their biological properties JO - Curr Med Chem VL - 12 UR - https://doi.org/10.2174/0929867053202214 DO - 10.2174/0929867053202214 ID - Yogeeswari2005 ER - TY - JOUR AU - Cloer, E. W. AU - Goldfarb, D. AU - Schrank, T. P. AU - Weissman, B. E. AU - Major, M. B. PY - 2019 DA - 2019// TI - NRF2 activation in cancer: from DNA to protein JO - Cancer Res VL - 79 UR - https://doi.org/10.1158/0008-5472.CAN-18-2723 DO - 10.1158/0008-5472.CAN-18-2723 ID - Cloer2019 ER - TY - JOUR AU - Towers, C. G. AU - Fitzwalter, B. E. AU - Regan, D. P. AU - Goodspeed, A. AU - Morgan, M. J. AU - Liu, C. PY - 2019 DA - 2019// TI - Cancer cells upregulate NRF2 signaling to adapt to autophagy inhibition JO - Dev Cell VL - 50 UR - https://doi.org/10.1016/j.devcel.2019.07.010 DO - 10.1016/j.devcel.2019.07.010 ID - Towers2019 ER - TY - JOUR AU - Slattery, M. L. AU - Lundgreen, A. AU - Kadlubar, S. AU - Bondurant, K. L. AU - Wolff, R. K. PY - 2013 DA - 2013// TI - JAK/STAT/SOCS-signaling pathway and colon and rectal cancer JO - Mol Carcinog VL - 52 UR - https://doi.org/10.1002/mc.21841 DO - 10.1002/mc.21841 ID - Slattery2013 ER - TY - JOUR AU - Passamonti, F. AU - Maffioli, M. AU - Caramazza, D. AU - Cazzola, M. PY - 2011 DA - 2011// TI - Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies JO - Oncotarget. VL - 2 UR - https://doi.org/10.18632/oncotarget.281 DO - 10.18632/oncotarget.281 ID - Passamonti2011 ER - TY - JOUR AU - Thomas, S. AU - Snowden, J. A. AU - Zeidler, M. P. AU - Danson, S. PY - 2015 DA - 2015// TI - The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours JO - Br J Cancer VL - 113 UR - https://doi.org/10.1038/bjc.2015.233 DO - 10.1038/bjc.2015.233 ID - Thomas2015 ER - TY - JOUR AU - Guertin, D. A. AU - Sabatini, D. M. PY - 2007 DA - 2007// TI - Defining the role of mTOR in cancer JO - Cancer Cell VL - 12 UR - https://doi.org/10.1016/j.ccr.2007.05.008 DO - 10.1016/j.ccr.2007.05.008 ID - Guertin2007 ER - TY - JOUR AU - Skeen, J. AU - Bhaskar, P. T. AU - Chen, C. C. AU - Chen, W. S. AU - Peng, X. D. AU - Nogueira, V. PY - 2006 DA - 2006// TI - Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner JO - Cancer Cell VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.08.022 DO - 10.1016/j.ccr.2006.08.022 ID - Skeen2006 ER - TY - JOUR AU - Easton, J. AU - Houghton, P. J. PY - 2006 DA - 2006// TI - mTOR and cancer therapy JO - Oncogene. VL - 25 UR - https://doi.org/10.1038/sj.onc.1209886 DO - 10.1038/sj.onc.1209886 ID - Easton2006 ER - TY - JOUR AU - Kuo, C. J. AU - Huang, C. C. AU - Chou, S. Y. AU - Lo, Y. C. AU - Kao, T. J. AU - Huang, N. K. PY - 2019 DA - 2019// TI - Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex JO - Phytomedicine VL - 54 UR - https://doi.org/10.1016/j.phymed.2018.09.203 DO - 10.1016/j.phymed.2018.09.203 ID - Kuo2019 ER - TY - JOUR AU - Liu, X. AU - Jiang, Q. AU - Liu, H. AU - Luo, S. PY - 2019 DA - 2019// TI - Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells JO - Biol Res VL - 52 UR - https://doi.org/10.1186/s40659-018-0209-0 DO - 10.1186/s40659-018-0209-0 ID - Liu2019 ER - TY - JOUR AU - Paquette, M. AU - Elhoujeiri, L. AU - Pause, A. PY - 2018 DA - 2018// TI - mTOR pathways in cancer and autophagy JO - Cancers VL - 10 UR - https://doi.org/10.3390/cancers10010018 DO - 10.3390/cancers10010018 ID - Paquette2018 ER - TY - JOUR AU - Morselli, E. AU - Galluzzi, L. AU - Kepp, O. AU - Vicencio, J. AU - Criollo, A. AU - Maiuri, M. C. AU - Kroemer, G. PY - 2009 DA - 2009// TI - Anti- and pro-tumor functions of autophagy JO - Biochim Biophys Acta VL - 1793 UR - https://doi.org/10.1016/j.bbamcr.2009.01.006 DO - 10.1016/j.bbamcr.2009.01.006 ID - Morselli2009 ER - TY - JOUR AU - Jiang, J. AU - Pi, J. AU - Jin, H. AU - Cai, J. PY - 2019 DA - 2019// TI - Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways JO - J Cell Biochem VL - 120 UR - https://doi.org/10.1002/jcb.27654 DO - 10.1002/jcb.27654 ID - Jiang2019 ER - TY - JOUR AU - Tian, Y. AU - Jia, S. AU - Shi, J. AU - Gong, G. AU - Yu, J. AU - Niu, Y. PY - 2019 DA - 2019// TI - Polyphyllin I induces apoptosis and autophagy via modulating JNK and mTOR pathways in human acute myeloid leukemia cells JO - Chem Biol Interact VL - 311 UR - https://doi.org/10.1016/j.cbi.2019.108793 DO - 10.1016/j.cbi.2019.108793 ID - Tian2019 ER -